Market Overview:
The global glycobiology instruments market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for glycomics and proteomics research, rising prevalence of chronic diseases, and growing investments by pharmaceutical and biotechnology companies in R&D activities. Based on type, the global glycobiology instruments market is segmented into mass spectrometry instruments, chromatography instruments, arrays, and other instruments. Mass spectrometry Instruments held the largest share of the global glycobiology instrument market in 2017 owing to its ability to identify complex sugar molecules with high accuracy.
Product Definition:
Glycobiology Instruments are used to study the structure and function of glycans. Glycans are important for many biological processes, including cell signaling, immune response, and protein folding.
Mass Spectrometry Instruments:
Mass spectrometry is a analytical technology that allows the identification of unknown compounds and quantification of known ones. It is used for the separation and analysis of molecules in different forms, which include peptides, proteins, ions & neutral compounds among others. The technique has been applied to various fields such as pharmaceuticals research (protein sequencing), food industry (foodomics), environmental science (monitoring pollution levels) and chemical industry (monitoring chemical composition).
Chromatography Instruments:
Chromatography is a technique used for separation and analysis of molecules. It works on the basis of different properties that are exhibited by compounds due to their molecular structure.
Application Insights:
The academic research institutes segment dominated the global glycobiology instruments market in 2017. This can be attributed to rising number of R&D activities being undertaken by various companies and institutions for discovery of novel drugs with improved efficacy and reduced adverse effects. Glycobiology is gaining prominence as it deals with study of sugars at molecular level which includes their functions, structure, biochemistry, diseases & disorders related to them along with solutions to existing problems associated with them. Henceforth, increasing R&D activities pertaining to glyco science will boost the growth of this segment over the forecast period.
Pharmaceutical and biotechnology companies are also undertaking significant research on discovery of new medicines through bio-organic chemistry that targets specific cells or organisms using natural sugars as a scaffold or building blocks for drug development.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in research activities related to glycomics and an increase in funding for such research. The region is expected to maintain its dominance over the forecast period due to an increase in R&D expenditure by pharmaceutical and biotechnology companies. In addition, increasing investments by academic institutions are also contributing towards growth of this regional market. For instance, as per a recent article published by Clinical Chemistry Journal, North American Glycobiology Society (NAGS) has collaborated with Diabetes Canada for supporting clinical chemistry conferences that will be held annually from 2018 onwards under the name Canadian Glycobiology Conference (CGC).
Asia Pacific is anticipated to grow at maximum rate during the forecast period owing high R&D investment and low cost of living compared with developed regions such as North America or Europe.
Growth Factors:
- Increasing demand for novel therapeutics and diagnostics: The global glycobiology instruments market is expected to grow at a CAGR of over 9% during the forecast period. This can be attributed to the increasing demand for novel therapeutics and diagnostics, which are based on glycomics and proteomics.
- Growing research funding for glycobiology: The growing research funding for glycobiology is another major growth driver of this market. Governments and private organizations are investing heavily in R&D activities related to glycobiology, thereby driving the growth of this market.
- Technological advancements: The development of innovative technologies has been a key factor driving the growth of the global glycobiology instruments market over the past few years. This trend is likely to continue in the coming years as well, resulting in further expansion of this market.
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycobiology Instruments Market Research Report
By Type
Mass Spectrometry Instruments, Chromatography Instruments, Arrays, Other Instruments
By Application
Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories
By Companies
Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Asparia Glycomics, S-BIO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Glycobiology Instruments Market Report Segments:
The global Glycobiology Instruments market is segmented on the basis of:
Types
Mass Spectrometry Instruments, Chromatography Instruments, Arrays, Other Instruments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Agilent Technologies
- Thermo Fisher Scientific
- New England Biolabs
- Shimadzu Corporation
- Asparia Glycomics
- S-BIO
Highlights of The Glycobiology Instruments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments
- By Application:
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycobiology Instruments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycobiology Instruments is a company that manufactures and sells laboratory equipment for the study of glycans.
Some of the major players in the glycobiology instruments market are Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Asparia Glycomics, S-BIO.
The glycobiology instruments market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glycobiology Instruments Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glycobiology Instruments Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glycobiology Instruments Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glycobiology Instruments Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glycobiology Instruments Market Size & Forecast, 2018-2028
4.5.1 Glycobiology Instruments Market Size and Y-o-Y Growth
4.5.2 Glycobiology Instruments Market Absolute $ Opportunity
Chapter 5 Global Glycobiology Instruments Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glycobiology Instruments Market Size Forecast by Type
5.2.1 Mass Spectrometry Instruments
5.2.2 Chromatography Instruments
5.2.3 Arrays
5.2.4 Other Instruments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glycobiology Instruments Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glycobiology Instruments Market Size Forecast by Applications
6.2.1 Academic Research Institutes
6.2.2 Pharmaceutical and Biotechnology Companies
6.2.3 Clinical Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glycobiology Instruments Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glycobiology Instruments Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glycobiology Instruments Analysis and Forecast
9.1 Introduction
9.2 North America Glycobiology Instruments Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glycobiology Instruments Market Size Forecast by Type
9.6.1 Mass Spectrometry Instruments
9.6.2 Chromatography Instruments
9.6.3 Arrays
9.6.4 Other Instruments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glycobiology Instruments Market Size Forecast by Applications
9.10.1 Academic Research Institutes
9.10.2 Pharmaceutical and Biotechnology Companies
9.10.3 Clinical Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glycobiology Instruments Analysis and Forecast
10.1 Introduction
10.2 Europe Glycobiology Instruments Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glycobiology Instruments Market Size Forecast by Type
10.6.1 Mass Spectrometry Instruments
10.6.2 Chromatography Instruments
10.6.3 Arrays
10.6.4 Other Instruments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glycobiology Instruments Market Size Forecast by Applications
10.10.1 Academic Research Institutes
10.10.2 Pharmaceutical and Biotechnology Companies
10.10.3 Clinical Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glycobiology Instruments Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glycobiology Instruments Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glycobiology Instruments Market Size Forecast by Type
11.6.1 Mass Spectrometry Instruments
11.6.2 Chromatography Instruments
11.6.3 Arrays
11.6.4 Other Instruments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glycobiology Instruments Market Size Forecast by Applications
11.10.1 Academic Research Institutes
11.10.2 Pharmaceutical and Biotechnology Companies
11.10.3 Clinical Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glycobiology Instruments Analysis and Forecast
12.1 Introduction
12.2 Latin America Glycobiology Instruments Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glycobiology Instruments Market Size Forecast by Type
12.6.1 Mass Spectrometry Instruments
12.6.2 Chromatography Instruments
12.6.3 Arrays
12.6.4 Other Instruments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glycobiology Instruments Market Size Forecast by Applications
12.10.1 Academic Research Institutes
12.10.2 Pharmaceutical and Biotechnology Companies
12.10.3 Clinical Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glycobiology Instruments Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glycobiology Instruments Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glycobiology Instruments Market Size Forecast by Type
13.6.1 Mass Spectrometry Instruments
13.6.2 Chromatography Instruments
13.6.3 Arrays
13.6.4 Other Instruments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glycobiology Instruments Market Size Forecast by Applications
13.10.1 Academic Research Institutes
13.10.2 Pharmaceutical and Biotechnology Companies
13.10.3 Clinical Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glycobiology Instruments Market: Competitive Dashboard
14.2 Global Glycobiology Instruments Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck KGaA
14.3.2 Agilent Technologies
14.3.3 Thermo Fisher Scientific
14.3.4 New England Biolabs
14.3.5 Shimadzu Corporation
14.3.6 Asparia Glycomics
14.3.7 S-BIO
